Wellbiotec Co. Ltd. Cash Flow Conversion Efficiency
Wellbiotec Co. Ltd. cash flow conversion efficiency. Based on the latest financial reports, Wellbiotec Co. Ltd. (010600) has a cash flow conversion efficiency ratio of -0.033x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-656.53 Million ≈ $-444.92K USD) by net assets (₩20.18 Billion ≈ $13.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Wellbiotec Co. Ltd. (2005–2024)
Cash flow conversion efficiency of Wellbiotec Co. Ltd. from 2005 to 2024. This chart illustrates how Wellbiotec Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Wellbiotec Co. Ltd. stock quote for real-time trading data and today's change.
Wellbiotec Co. Ltd. Cash Flow Conversion Ratio Explained
Wellbiotec Co. Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Wellbiotec Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wellbiotec Co. Ltd. ranked by their cash flow conversion efficiency. Also see market cap of Wellbiotec Co. Ltd. for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SHL Telemedicine Ltd American Depositary Shares
NASDAQ:SHLT
|
-0.004x |
|
SK Chemicals Co Ltd Pref
KO:28513K
|
0.000x |
|
Topmix Berhad
KLSE:0302
|
0.013x |
|
Fridenson
TA:FRDN
|
-0.054x |
|
Asia Plastic Recycling Holding Ltd
TW:1337
|
-0.017x |
|
Peoplein Ltd
AU:PPE
|
0.110x |
|
Jinli Group Holdings Ltd
TW:8429
|
0.001x |
|
Enapter AG
F:H2O
|
-0.140x |
Annual Cash Flow Conversion Efficiency for Wellbiotec Co. Ltd. (2005–2024)
The table below shows the annual cash flow conversion efficiency of Wellbiotec Co. Ltd. from 2005 to 2024. Review free cash flow generation of Wellbiotec Co. Ltd. to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩20.18 Billion ≈ $13.68 Million |
₩-6.08 Billion ≈ $-4.12 Million |
-0.301x | -168.83% |
| 2023-12-31 | ₩37.22 Billion ≈ $25.22 Million |
₩-4.17 Billion ≈ $-2.82 Million |
-0.112x | -261.35% |
| 2022-12-31 | ₩37.80 Billion ≈ $25.61 Million |
₩2.62 Billion ≈ $1.78 Million |
0.069x | +224.24% |
| 2021-12-31 | ₩33.31 Billion ≈ $22.57 Million |
₩712.97 Million ≈ $483.17K |
0.021x | +107.31% |
| 2020-12-31 | ₩19.49 Billion ≈ $13.21 Million |
₩-5.70 Billion ≈ $-3.87 Million |
-0.293x | -186.49% |
| 2019-12-31 | ₩75.64 Billion ≈ $51.26 Million |
₩-7.73 Billion ≈ $-5.24 Million |
-0.102x | +15.84% |
| 2018-12-31 | ₩76.40 Billion ≈ $51.78 Million |
₩-9.27 Billion ≈ $-6.29 Million |
-0.121x | +18.88% |
| 2017-12-31 | ₩26.85 Billion ≈ $18.20 Million |
₩-4.02 Billion ≈ $-2.72 Million |
-0.150x | -114.19% |
| 2016-12-31 | ₩33.86 Billion ≈ $22.95 Million |
₩-2.37 Billion ≈ $-1.60 Million |
-0.070x | -159.74% |
| 2015-12-31 | ₩36.57 Billion ≈ $24.78 Million |
₩4.28 Billion ≈ $2.90 Million |
0.117x | +367.71% |
| 2014-12-31 | ₩35.12 Billion ≈ $23.80 Million |
₩-1.53 Billion ≈ $-1.04 Million |
-0.044x | -275.96% |
| 2013-12-31 | ₩40.69 Billion ≈ $27.57 Million |
₩1.01 Billion ≈ $684.60K |
0.025x | -70.75% |
| 2012-12-31 | ₩36.04 Billion ≈ $24.42 Million |
₩3.06 Billion ≈ $2.07 Million |
0.085x | +10.03% |
| 2010-12-31 | ₩37.64 Billion ≈ $25.51 Million |
₩2.90 Billion ≈ $1.97 Million |
0.077x | +17.27% |
| 2008-12-31 | ₩47.27 Billion ≈ $32.03 Million |
₩3.11 Billion ≈ $2.11 Million |
0.066x | -39.44% |
| 2006-12-31 | ₩41.38 Billion ≈ $28.04 Million |
₩4.49 Billion ≈ $3.05 Million |
0.109x | +178.98% |
| 2005-12-31 | ₩37.91 Billion ≈ $25.69 Million |
₩1.48 Billion ≈ $1.00 Million |
0.039x | -- |
About Wellbiotec Co. Ltd.
Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, hand bags, car seats, and handle covers. It also offers development, production, and sell of medicines and health functional foods; logistics consulting, transportation agency services, customs clearance, insurance, and storage services; and general and spe… Read more